Nippon India Pharma Fund - IDCW Option - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Status: Open
Portfolio Overview
As of February 28, 2026
Asset Allocation
Equity: 99.70%Others: 0.30%
Market Cap
Large Cap: 31.13%Mid Cap: 38.79%Small Cap: 28.89%Others: 0.89%
Number of stocks
35
Top 10 Holdings
116.77% of portfolio
Market Cap of Equity
Large Cap
31.1264%
Mid Cap
38.7855%
Small Cap
28.8903%
Others
0.8936%
Companies Allocation of Equity
Sun Pharmaceuticals Industries Ltd26.17%
Lupin Ltd15.98%
Divi's Laboratories Ltd13.13%
Dr Reddy's Laboratories Ltd11.61%
Cipla Ltd11.35%
Apollo Hospitals Enterprise Ltd10.34%
Medplus Health Services Ltd7.40%
Max Healthcare Institute Ltd Ordinary Shares6.99%
Vijaya Diagnostic Centre Ltd6.98%
Ajanta Pharma Ltd6.82%
Sector Allocation of Equity
Healthcare99.70%
SIP Amount
Monthly SIP Date
Nippon India Pharma Fund - IDCW Option


Is This Mutual Fund Right for You?
+10k investors used our Suitability Test to get better returns
Fund Suitability Test
Let's Get Started.
Frequently Asked Questions
Everything You Need To Know To Get Started With Confidence
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.